Massachusetts’ EarlySense Receives FDA Clearance For Bedside System & Central Display System With Oximetry Integration
Circle Connections: Tech Updates EarlySense, the market leader in proactive patient care solutions, announced today that the company has received FDA Clearance for its bedside system and central display system with oximetry integration. This coincides with the Joint Commission's recently issued Sentinel Event Alert (the Alert) on the safe use of opioids in hospitals which recommends implementing better dosing along with oxygenation and ventilation monitoring in post-surgical patients. The Alert states that opioid analgesics, a painkiller widely used to treat post-surgical patients, may be associated with adverse effects, the most serious effect being respiratory depression, which can . . .


